FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimers disease.

Petr Novak; Reinhold Schmidt; Eva Kontsekova; Branislav Kovacech; Tomas Smolek; Stanislav Katina; Lubica Fialova; Michal Prcina; Vojtech Parrak; Peter Dal-Bianco; Martin Brunner; Wolfgang Staffen; Michael Rainer; Matej Ondrus; Stefan Ropele; Miroslav Smisek; Roman Sivak; Norbert Zilka; Bengt Winblad; Michal Novak

doi:10.1186/s13195-018-0436-1

FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimers disease.

Petr Novak
, Reinhold Schmidt
, Eva Kontsekova
, Branislav Kovacech
, Tomas Smolek
, Stanislav Katina
, Lubica Fialova
, Michal Prcina
, Vojtech Parrak
, Peter Dal-Bianco
, Martin Brunner
, Wolfgang Staffen (Co-Autor/-in)
, Michael Rainer
, Matej Ondrus
, Stefan Ropele
, Miroslav Smisek
, Roman Sivak
, Norbert Zilka
, Bengt Winblad
, Michal Novak

Universitätsklinik für Neurologie, neurologische Intensivmedizin und Neurorehabilitation

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

111 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	108
Fachzeitschrift	Alzheimer's Research & Therapy
Jahrgang	10
Ausgabenummer	1
DOIs	https://doi.org/10.1186/s13195-018-0436-1
Publikationsstatus	Veröffentlicht - 2018

Zugriff auf Dokument

10.1186/s13195-018-0436-1

Dieses zitieren

Novak, P., Schmidt, R., Kontsekova, E., Kovacech, B., Smolek, T., Katina, S., Fialova, L., Prcina, M., Parrak, V., Dal-Bianco, P., Brunner, M., Staffen, W., Rainer, M., Ondrus, M., Ropele, S., Smisek, M., Sivak, R., Zilka, N., Winblad, B., & Novak, M. (2018). FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimers disease. Alzheimer's Research & Therapy, 10(1), 108. https://doi.org/10.1186/s13195-018-0436-1

@article{ecce6d1587b14f1bbdcf33d9bd112108,

title = "FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimers disease.",

keywords = "TRUNCATED TAU, MOUSE MODEL, DEMENTIA, ANTIBODY, IMMUNOGENICITY, ACCURATE, TRIALS, SAFETY, ROBUST, AN1792",

author = "Petr Novak and Reinhold Schmidt and Eva Kontsekova and Branislav Kovacech and Tomas Smolek and Stanislav Katina and Lubica Fialova and Michal Prcina and Vojtech Parrak and Peter Dal-Bianco and Martin Brunner and Wolfgang Staffen and Michael Rainer and Matej Ondrus and Stefan Ropele and Miroslav Smisek and Roman Sivak and Norbert Zilka and Bengt Winblad and Michal Novak",

note = "Staffen, W: University Clinic of Neurology, Christian-Doppler-Clinic, Ignaz-Harrer-Stra{\ss}e 79, 5020 Salzburg, Austria",

year = "2018",

doi = "10.1186/s13195-018-0436-1",

language = "English",

volume = "10",

pages = "108",

journal = "Alzheimer's Research \& Therapy",

issn = "1758-9193",

number = "1",

}

Novak, P, Schmidt, R, Kontsekova, E, Kovacech, B, Smolek, T, Katina, S, Fialova, L, Prcina, M, Parrak, V, Dal-Bianco, P, Brunner, M, Staffen, W, Rainer, M, Ondrus, M, Ropele, S, Smisek, M, Sivak, R, Zilka, N, Winblad, B & Novak, M 2018, 'FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimers disease.', Alzheimer's Research & Therapy, Jg. 10, Nr. 1, S. 108. https://doi.org/10.1186/s13195-018-0436-1

TY - JOUR

T1 - FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimers disease.

AU - Novak, Petr

AU - Schmidt, Reinhold

AU - Kontsekova, Eva

AU - Kovacech, Branislav

AU - Smolek, Tomas

AU - Katina, Stanislav

AU - Fialova, Lubica

AU - Prcina, Michal

AU - Parrak, Vojtech

AU - Dal-Bianco, Peter

AU - Brunner, Martin

AU - Staffen, Wolfgang

AU - Rainer, Michael

AU - Ondrus, Matej

AU - Ropele, Stefan

AU - Smisek, Miroslav

AU - Sivak, Roman

AU - Zilka, Norbert

AU - Winblad, Bengt

AU - Novak, Michal

N1 - Staffen, W: University Clinic of Neurology, Christian-Doppler-Clinic, Ignaz-Harrer-Straße 79, 5020 Salzburg, Austria

PY - 2018

Y1 - 2018

KW - TRUNCATED TAU

KW - MOUSE MODEL

KW - DEMENTIA

KW - ANTIBODY

KW - IMMUNOGENICITY

KW - ACCURATE

KW - TRIALS

KW - SAFETY

KW - ROBUST

KW - AN1792

U2 - 10.1186/s13195-018-0436-1

DO - 10.1186/s13195-018-0436-1

M3 - Original Article

C2 - 30355322

SN - 1758-9193

VL - 10

SP - 108

JO - Alzheimer's Research & Therapy

JF - Alzheimer's Research & Therapy

IS - 1

ER -